$100 million-plus rounds used to be rare. Now, 40% of seed and Series A rounds are clearing that bar

Core Insights - The investment landscape for AI has dramatically shifted, with over 40% of seed and Series A funding in 2026 exceeding $100 million, indicating a normalization of large funding rounds [1][2] Venture Capital - Notable recent funding rounds include Humans& raising $480 million, Ricursive Intelligence securing $300 million, and Merge Labs obtaining $252 million [2] - Decacon raised $250 million for AI concierge services, while Oviva secured €200 million ($239 million) for digital care solutions [7] - Flapping Airplanes raised $180 million, and RobCo received $100 million in Series C funding [8] - Talos raised $45 million in Series B extension, and Recare secured €37 million ($44 million) for discharge management [9] - Revena and Datalinx AI raised $8 million and $4.2 million in seed funding, respectively [10] Private Equity - Capstreet acquired TOPS Field Services, and Conquest Research acquired NeuroTrials Research, with financial terms undisclosed [11] - HF Companies and Inspirit Equity also made acquisitions, with details not disclosed [12] IPOs - Liftoff Mobile plans to raise up to $762 million in an offering of 25.4 million shares priced between $26 and $30 [13] - AgomAb Therapeutics aims to raise up to $212.5 million in an offering of 12.5 million shares priced between $15 and $17 [14] - Ethos Technologies raised $200 million in an offering of 10.5 million shares priced at $19 [15] - SpyGlass Pharma plans to raise up to $159.8 million in an offering of 9.4 million shares priced between $15 and $17 [16] Funds - 2048 Ventures raised $82 million for its third fund focused on AI, deep tech, healthcare, and biotech startups [17] People - 2048 Ventures promoted Daniella Cohen to principal, while Bessemer Venture Partners promoted Sam Bondy to Vice President [18] - Summit Partners made several promotions, including Chris Bon and Meg Devine to partner [19]